A detailed history of Morgan Stanley transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Morgan Stanley holds 43,100 shares of CSBR stock, worth $171,107. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,100
Previous 40,700 5.9%
Holding current value
$171,107
Previous $199,000 11.56%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 17, 2024

BUY
$4.5 - $5.23 $10,800 - $12,552
2,400 Added 5.9%
43,100 $222,000
Q2 2024

Aug 14, 2024

BUY
$4.5 - $5.23 $10,800 - $12,552
2,400 Added 5.9%
43,100 $222,000
Q1 2024

Oct 17, 2024

SELL
$4.9 - $6.91 $11,760 - $16,584
-2,400 Reduced 5.57%
40,700 $199,000
Q1 2024

Aug 16, 2024

BUY
$4.9 - $6.91 $154,840 - $218,356
31,600 Added 347.25%
40,700 $199,000
Q1 2024

May 15, 2024

BUY
$4.9 - $6.91 $154,840 - $218,356
31,600 Added 347.25%
40,700 $199,000
Q4 2023

Aug 16, 2024

SELL
$4.56 - $6.59 $155,040 - $224,060
-34,000 Reduced 78.89%
9,100 $51,000
Q4 2023

Feb 13, 2024

SELL
$4.56 - $6.59 $9,120 - $13,180
-2,000 Reduced 18.02%
9,100 $51,000
Q2 2023

Aug 14, 2023

BUY
$4.11 - $6.81 $8,220 - $13,620
2,000 Added 21.98%
11,100 $70,000
Q1 2023

May 15, 2023

BUY
$4.0 - $4.67 $4,824 - $5,632
1,206 Added 15.28%
9,100 $36,000
Q4 2022

Feb 14, 2023

BUY
$3.75 - $7.69 $352 - $722
94 Added 1.21%
7,894 $35,000
Q3 2022

Nov 14, 2022

BUY
$7.21 - $9.47 $17,304 - $22,728
2,400 Added 44.44%
7,800 $59,000
Q2 2022

Oct 27, 2022

SELL
$6.81 - $8.31 $9,574 - $11,683
-1,406 Reduced 20.66%
5,400 $43,000
Q2 2022

Aug 15, 2022

SELL
$6.81 - $8.31 $9,574 - $11,683
-1,406 Reduced 20.66%
5,400 $43,000
Q1 2022

Oct 27, 2022

BUY
$7.26 - $8.53 $10,207 - $11,993
1,406 Added 26.04%
6,806 $55,000
Q1 2022

May 13, 2022

SELL
$7.26 - $8.53 $5,285 - $6,209
-728 Reduced 9.66%
6,806 $55,000
Q4 2021

Feb 14, 2022

BUY
$7.76 - $10.23 $4,725 - $6,230
609 Added 8.79%
7,534 $63,000
Q3 2021

Nov 15, 2021

BUY
$9.11 - $10.96 $63,086 - $75,898
6,925 New
6,925 $70,000

Others Institutions Holding CSBR

About CHAMPIONS ONCOLOGY, INC.


  • Ticker CSBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,522,400
  • Market Cap $53.7M
  • Description
  • Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...
More about CSBR
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.